文献速递神经肌肉病

肌原纤维肌病及MFM相关基因肌病的自然史与表型谱

Natural History and Phenotypic Spectrum of Myofibrillar Myopathies and Myopathies Associated With MFM-Related Genes.
PubMed 文献 · Neurology · 2025-11-03

结蛋白病相比肌动蛋白病和LDB3相关肌病,心脏受累更早更多、呼吸受累更频繁、更早依赖步态辅助,但丧失行走能力的年龄和死亡率无差异。

要点

  • 结蛋白病患者心脏受累更早(p<0.001)、呼吸受累更多(p=0.029)、更早需步态辅助(p=0.018)。
  • 所有患者均有肌无力,以远端为主(34例),其次近端为主(24例)和弥漫性(11例)。
  • 60岁前结蛋白病患者67%需步态辅助、31%需轮椅,肌动蛋白病为12%和0%,LDB3相关肌病为25%和0%。

核心结论

  • MFM及MFM相关基因肌病临床异质性大,结蛋白病心脏表现更早、步态辅助需求更早、心肺受累更频繁,遗传诊断对管理和预后至关重要。

研究设计与样本

  • 56例完成基因 characterization:23例DES、10例MYOT、9例LDB3、2例FLNC、2例BAG3、2例CRYAB、1例FHL1、7例其他。
  • 65例接受活检,其中60例观察到肌原纤维病理。

主要发现

  • 中位症状起始年龄42.3岁(IQR 20.2-57.0),66例以肌肉起病、14例以心脏起病。
  • 中位病程13.1年(IQR 8.1-24.0),全部患者有肌无力,远端为主34例、近端为主24例、弥漫性11例。
  • 吞咽困难16例,其中4例需喂养管;周围神经病21例(大纤维轴索性13例、小纤维性8例),多较轻。
  • 46例需步态辅助(中位起病后10.0年),17例需轮椅(中位起病后19.0年)。
  • 心脏受累31例、呼吸受累33例,分别在肌病起病后中位7年和9年出现;7例死亡,主要因心肺并发症。

关键数值与推荐

  • 60岁前,结蛋白病患者67%需步态辅助、31%需轮椅,肌动蛋白病患者12%和0%,LDB3相关肌病患者25%和0%。
  • 结蛋白病相比其他组:心脏受累更早更多(p<0.001)、呼吸受累更频繁(p=0.029)、更早依赖步态辅助(p=0.018)、周围神经病患病率更低(p=0.022)。
  • 结蛋白病与其他组在丧失行走能力年龄(p=0.418)和死亡率(p=1.000)上无差异。

临床怎么用

  • 对MFM相关基因肌病患者应进行遗传诊断以指导管理及预后判断。
  • 结蛋白病患者需更早筛查和监测心脏及呼吸受累,并关注步态辅助需求。
  • 对存在吞咽困难者评估喂养管需求,对周围神经病表现者结合临床识别。

局限性

  • 部分患者缺乏基因检测或未行活检,可能存在选择偏倚。
  • 原文未报告具体治疗干预对自然史的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Myofibrillar myopathy (MFM) is a pathologically defined but genetically heterogeneous myopathy; however, myofibrillar pathology may be absent in some patients with pathogenic variants in MFM-related genes. The natural history of MFM and myopathies associated with MFM-related genes remains poorly characterized. METHODS: We retrospectively reviewed patients evaluated at Mayo Clinic (January 1993-March 2024) with either pathologically confirmed MFM or myopathies associated with MFM-related genes. Patients without genetic testing or skeletal muscular manifestations were excluded. RESULTS: Eighty patients were identified; 56 were genetically characterized (23 with DES, 10 with MYOT, 9 with LDB3, 2 with FLNC, 2 with BAG3, 2 with CRYAB, 1 with FHL1, and 7 others). Myofibrillar pathology was observed in 60 of 65 biopsied patients. The median age at symptom onset was 42.3 years (interquartile range [IQR] 20.2-57.0); 66 presented with muscular onset and 14 with cardiac onset. With a median disease duration of 13.1 years (IQR 8.1-24.0) from symptom onset to last visit, all patients had weakness, commonly distal-predominant (n = 34), followed by proximal-predominant (n = 24) and diffuse (n = 11) weakness. Dysphagia occurred in 16 patients, with 4 requiring feeding tubes. Peripheral neuropathy was found in 21 patients (13 with axonal large fiber neuropathy and 8 with small fiber neuropathy), mostly mild in severity. Gait aids were required in 46 patients (median 10.0 years after onset), and 17 became wheelchair-bound (median 19.0 years after onset). By age 60, 67% and 31% of patients with desminopathy required gait aids and were wheelchair-bound, respectively, compared with 12% and 0% of those with myotilinopathy and 25% and 0% of those with LDB3-related myopathy. Cardiac involvement (n = 31) and respiratory involvement (n = 33) were frequent, manifesting at a median of 7 and 9 years, respectively, after myopathy onset. Seven patients (2 with DES, 1 with ACTA1, 4 genetically uncharacterized) died, mainly due to cardiopulmonary complications. Patients with desminopathy exhibited earlier and higher rates of cardiac involvement (p < 0.001), more frequent respiratory involvement (p = 0.029), earlier gait aid dependence (p = 0.018) despite a similar age at ambulation loss (p = 0.418), lower prevalence of peripheral neuropathy (p = 0.022), and a similar mortality rate (p = 1.000). DISCUSSION: MFM and myopathies associated with MFM-related genes are clinically heterogeneous, with desminopathy showing earlier cardiac manifestations and gait aid requirement and more frequent cardiopulmonary involvement. Given the phenotypic variability, genetic diagnosis is crucial for patient management and prognosis.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Wannarong T, Milone M, Selcen D, et al. Natural History and Phenotypic Spectrum of Myofibrillar Myopathies and Myopathies Associated With MFM-Related Genes. Neurology. 2025. PMID: 41183253. doi:10.1212/WNL.0000000000214255

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。